Search research articles
Contact Us
Filters
Showing results (271-280 of 289) with videos related to
Page
of 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 22, 2017
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E Palmerini, N S Chawla, S Ferrari, et al.
Virchows Archiv : an International Journal of Pathology
|
October 12, 2014
Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis
M Lieveld, E Bodson, G De Boeck, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 14, 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
E Palmerini, R L Jones, E Setola, et al.
Oncogene
|
August 1, 1996
SV40-like sequences in human bone tumors
M Carbone, P Rizzo, A Procopio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 10, 2012
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
R Luksch, A Tienghi, K Sundby Hall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2012
Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall
A Gronchi, P Verderio, A De Paoli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2007
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours
R Luksch, G Grignani, F Fagioli, et al.
Oncogene
|
August 9, 2011
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
C Mackintosh, J L Ordóñez, D J García-Domínguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities
P Picci, T Böhling, G Bacci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
S Ferrari, K Sundby Hall, R Luksch, et al.
Page
of 29
Search research articles
Search
Showing results (271-280 of 289) with videos related to
Sort By:
Page
of 29
European Journal of Cancer (Oxford, England : 1990)
|
March 22, 2017
Denosumab in advanced/unresectable giant-cell tumour of bone (GCTB): For how long?
E Palmerini, N S Chawla, S Ferrari, et al.
Virchows Archiv : an International Journal of Pathology
|
October 12, 2014
Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis
M Lieveld, E Bodson, G De Boeck, et al.
Acta Oncologica (Stockholm, Sweden)
|
March 14, 2018
Irinotecan and temozolomide in recurrent Ewing sarcoma: an analysis in 51 adult and pediatric patients
E Palmerini, R L Jones, E Setola, et al.
Oncogene
|
August 1, 1996
SV40-like sequences in human bone tumors
M Carbone, P Rizzo, A Procopio, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 10, 2012
Primary metastatic Ewing's family tumors: results of the Italian Sarcoma Group and Scandinavian Sarcoma Group ISG/SSG IV Study including myeloablative chemotherapy and total-lung irradiation
R Luksch, A Tienghi, K Sundby Hall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2012
Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall
A Gronchi, P Verderio, A De Paoli, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 27, 2007
Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours
R Luksch, G Grignani, F Fagioli, et al.
Oncogene
|
August 9, 2011
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
C Mackintosh, J L Ordóñez, D J García-Domínguez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1997
Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities
P Picci, T Böhling, G Bacci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 10, 2010
Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol
S Ferrari, K Sundby Hall, R Luksch, et al.
Page
of 29